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RNA chaperones are nonspecific nucleic acid binding proteins with long disordered regions that help RNA molecules to adopt its functional
conformation. Coronavirus nucleoproteins (N) are nonspecific RNA-binding proteins with long disordered regions. Therefore, we investigated
whether transmissible gastroenteritis coronavirus (TGEV) N protein was an RNA chaperone. Purified N protein enhanced hammerhead ribozyme
self-cleavage and nucleic acids annealing, which are properties that define RNA chaperones. In contrast, another RNA-binding protein, PTB, did
not show these activities. N protein chaperone activity was blocked by specific monoclonal antibodies. Therefore, it was concluded that TGEV N
protein is an RNA chaperone. In addition, we have shown that purified severe acute respiratory syndrome (SARS)-CoV N protein also has RNA
chaperone activity. In silico predictions of disordered domains showed a similar pattern for all coronavirus N proteins evaluated. Altogether, these
data led us to suggest that all coronavirus N proteins might be RNA chaperones.
© 2006 Elsevier Inc. All rights reserved.Keywords: RNA chaperone; Coronavirus; Nidovirus; RNA synthesisIntroduction
RNAmolecules easily misfold because of their structural and
functional flexibility and become trapped in inactive conforma-
tions that can be very stable and persistent (known as the RNA
folding problem) (Herschlag, 1995). RNA chaperones are
nucleic acid binding proteins, with broad specificity, that rescue
RNAs trapped in unproductive folding states (Cristofari and
Darlix, 2002; Herschlag, 1995; Lorsch, 2002; Schroeder et al.,
2004). The main characteristic distinguishing RNA chaperones
from other RNA-binding proteins is that, once the RNA has
been folded, they are no longer needed and can be removed
without altering RNA conformation. The number of proteins
with RNA chaperone activity is growing steadily (Cristofari and
Darlix, 2002; Rajkowitsch et al., 2005). There are several assays
to analyze the RNA chaperone activity of a protein in vitro
(Cristofari and Darlix, 2002), but only recently it has been
shown that a protein acts as an RNA chaperone in vivo (Clodi et⁎ Corresponding author. Fax: +34 91 585 4915.
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doi:10.1016/j.virol.2006.07.046al., 1999; Mohr et al., 2002). This could be due, at least in part,
to the pleiotropic effects that RNA chaperones can cause when
they aremutated. In vitro, RNAchaperones (i) enhance ribozyme
cleavage, (ii) enable rapid and accurate RNA annealing, and (iii)
facilitate strand transfer and exchange. Among these activities,
the first one is the most stringent for an RNA chaperone and
requires the other two activities (Rajkowitsch et al., 2005).
There is a growing number of cellular RNA chaperones, both
prokaryotic and eukaryotic (Cristofari and Darlix, 2002;
Schroeder et al., 2004). However, up to date, only a few virus-
encoded RNA chaperones have been described: (i) retroviral
nucleocapsid proteins, the best studied being the NCp7 protein
from human immunodeficiency virus (HIV-1) (Bertrand and
Rossi, 1994; Hong et al., 2003; Tsuchihashi and Brown, 1994),
(ii) delta antigen from hepatitis delta virus (HDV), that is the
only protein encoded by this viroid RNA (Huang et al., 2003;
Huang and Wu, 1998; Wang et al., 2003), (iii) the core protein
from hepatitis C virus (HCV) (Cristofari et al., 2004), (iv)
hantavirus N protein (Mir and Panganiban, 2005, 2006), and (v)
poliovirus 3AB protein (DeStefano and Titilope, 2006). Most of
these viruses have RNA genomes requiring tightly regulated
216 S. Zúñiga et al. / Virology 357 (2007) 215–227ribozyme activities, nucleic acid strand transfer, or annealing
steps in their life cycle. Four of the virus-encoded RNA
chaperones described (NCp7, HDV antigen, HCV core and
Hantavirus N) are the nucleic acid binding proteins that pack the
genomic RNA to form the viral ribonucleoproteins. These
proteins are further required as RNA chaperones for several
processes during replication and transcription.
The order Nidovirales includes enveloped single-stranded,
positive-sense RNA viruses. A relevant characteristic of the
members of this virus order is that the 5′ two-thirds of the entire
RNA comprises open reading frames (ORFs) 1a and 1b
encoding the replicase (rep) (Enjuanes et al., 2000b; Gorbale-
nya et al., 2006). Nidovirales comprise the Coronaviridae
family that includes viruses with the largest known RNA
genome, around 30 kb. The 3′ one-third of their genome
includes the genes encoding the structural proteins, always in
the order: 5′-S-E-M-N-3′ (Enjuanes et al., 2000a), and genes
coding for non-structural proteins scattered among them.
Coronaviruses have been classified in: (i) group 1, the most
representative members being transmissible gastroenteritis
virus (TGEV) and human coronavirus (HCoV)-229E, (ii)
group 2a, the best studied being mouse hepatitis virus
(MHV), (iii) group 2b, created after the discovery of the
agent causing the severe acute respiratory syndrome (SARS),
and (iii) group 3, the most representative member being the
infectious bronchitis virus (IBV) (Enjuanes et al., 2000a;
Gorbalenya et al., 2006). The study of the molecular biology of
coronaviruses has increased its relevance since the identifica-
tion of SARS-CoV (Drosten et al., 2003; Fouchier et al., 2003;
Holmes and Enjuanes, 2003; Ksiazek et al., 2003; Kuiken et al.,
2003; Marra et al., 2003; Rota et al., 2003) and the discovery of
new human coronaviruses such as NL63 and HKU1 (van der
Hoek et al., 2004; Woo et al., 2005). Infectious cDNA clones
and replicons have been engineered by our group for TGEV
(Almazan et al., 2004; Almazán et al., 2000; González et al.,
2002) and SARS-CoV (Almazan et al., 2006), although other
infectious clones are available for several coronaviruses (St-
Jean et al., 2006; Thiel et al., 2001; Youn et al., 2005; Yount et
al., 2000, 2003).
Coronavirus replication and transcription are based on RNA-
dependent RNA synthesis. Replication of coronaviruses results
in a full-length copy of the genomic RNA (gRNA), whereas
transcription leads to the generation of a nested set of
subgenomic mRNAs of various sizes (Pasternak et al., 2006).
These mRNAs are 5′ and 3′-coterminal with the genome. A
leader sequence of 65 to 93 nucleotides, derived from the 5′ end
of the genome, is fused to the 5′ end of the mRNA coding
sequence (body) by a discontinuous transcription mechanism
(Pasternak et al., 2001; Sawicki and Sawicki, 1998; Zuñiga et
al., 2004). This process resembles a high-frequency similarity-
assisted copy-choice RNA recombination (Brian and Spaan,
1997; Nagy and Simon, 1997; Pasternak et al., 2003), in which
the transcription regulating sequences (TRSs) of the body
(TRS-B, donor) and leader (TRS-L, acceptor), located in distal
domains in the RNA primary structure, are probably brought
into physical proximity by RNA–protein and protein–protein
interactions. In fact, members of the heterogeneous nuclearribonucleoprotein (hnRNP) family, like hnRNP A1 and the
polypyrimidine tract binding protein (PTB), are involved in
MHV RNA synthesis (Choi et al., 2002; Huang and Lai, 2001;
Shi et al., 2000).
Coronavirus nucleocapsid (N) protein has a structural role as
it forms a ribonucleoprotein complex with gRNA. N protein
probably also has an important role in RNA synthesis (Baric et
al., 1988; Laude and Masters, 1995). In fact, at early times
postinfection, it colocalizes with the replication complex in the
sites of RNA synthesis (Bost et al., 2001; Denison et al., 1999),
and only background levels of coronavirus RNA synthesis are
produced in the absence of N protein (Almazan et al., 2004;
Schelle et al., 2005). Although nucleoproteins from different
coronaviruses are variable in length and primary sequence, a
conserved three-domain organization was proposed (Parker and
Masters, 1990). N protein domain II is more conserved than
domains I and III, especially in a serine-rich region that is
probably important for the biological function of N protein.
Recently, a modular organization without correlation with the
previously proposed three-domain structure, based on protein
disorder and common for all coronavirus N proteins, has been
proposed (Chang et al., 2006). Several domains in the N protein
have been mapped, such as the RNA-binding (Fan et al., 2005;
Huang et al., 2004; Nelson et al., 2000) and the oligomerization
(Fan et al., 2005; Hurst et al., 2005; Yu et al., 2005) domains.
In this report, we show that the N proteins from two
coronaviruses (TGEV and SARS-CoV) have RNA chaperone
activity. The possible conservation of this activity in coronavirus
N proteins and its potential role in RNA synthesis is discussed.
Results
Coronavirus N protein as an RNA chaperone candidate
Coronavirus N protein packs the genomic RNA, as do the
previously described virus-encoded RNA chaperones (Cristofari
et al., 2004; Huang and Wu, 1998; Levin et al., 2005). RNA
chaperones possess the highest frequency of intrinsically
disordered regions (Ivanyi-Nagy et al., 2005; Tompa and
Csermely, 2004). A modular organization of coronavirus N
protein has been proposed using the PONDR VSL1 predictor
(Iakoucheva et al., 2002; Romero et al., 1997), with two
organized domains separated by unstructured regions (Chang et
al., 2006). Intrinsically disordered regions of several coronavirus
N proteins were postulated using the DisProt VL3H predictor
(Obradovic et al., 2003; Peng et al., 2005), previously used for
the analysis of the correlation between intrinsic disorder and
chaperone function (Ivanyi-Nagy et al., 2005) (Fig. 1). RNA-
binding (Fan et al., 2005; Huang et al., 2004; Nelson et al., 2000)
and oligomerization (Fan et al., 2005; Hurst et al., 2005; Yu et al.,
2005) domains previously characterized have been included in
the graphic representations (Fig. 1, hatched regions). A good
correlation between the presence of disordered and ordered
regions and the 3D structure of different domains has been
identified (Fan et al., 2005; Huang et al., 2004), validating in
silico predictions of N protein domains. Long disordered regions
were predicted in all the N proteins analyzed (Fig. 1), postulating
Fig. 1. Prediction of intrinsically unstructured regions in coronavirus N proteins. Graphical representation of the disorder probability vs. amino acid position of N
proteins determined using DisProt VL3H. Nucleoproteins from coronavirus group 1 (TGEV, HCoV-229E), group 2a (MHV), group 2b (SARS-CoV), and group 3
(IBV) were analyzed. As indicated in the lower panel on the right, amino acids with a disorder score equal or above 0.5 are considered to be in a disordered
environment, while a value below 0.5 is considered ordered. The percentage of disorder covers more than 50% of the sequence in all cases: 52.62% (TGEV), 57.53%
(HCoV-229E), 57.27% (MHV), 61.85% (SARS-CoV), and 62.35% (IBV). Hatched regions indicate previously identified RNA-binding (RBD) and oligomerization
(OD) domains.
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regions, as expected for nucleic acid chaperones (Ivanyi-Nagy et
al., 2005). These observations, and the capacity of N protein to
bind RNA nonspecifically, opened the possibility that N protein
was an RNA chaperone candidate.
Recombinant N protein binds RNA nonspecifically
Previous results have shown that coronavirus N protein binds
RNA nonspecifically, although a higher affinity for leader and
TRSs sequences was described (Nelson et al., 2000). In addition,
in a recent report, it has been shown that IBV phosphorylated N
protein has higher affinity for viral sequences, especially leader
TRS, than for random RNAs (Chen et al., 2005). As a previous
step to analyze the RNA chaperone activity of N protein, its
binding to RNAwas tested. TGEV nucleoprotein was expressed
in Escherichia coli and purified as a GST-tagged protein. The
purified N protein was incubated with an excess of different
RNA oligonucleotides, representing viral TRSs or a cellularRNA, and the binding of N protein to RNA was detected by
electrophoretic mobility shift assay (EMSA). A band shift was
observed in all cases (Fig. 2A), indicating that GST-N protein
bound RNAwith broad specificity, as expected.
Blocking of TGEV N protein–RNA binding
A set of monoclonal antibodies (mAbs) recognizing
different domains of TGEV N protein, produced in our
laboratory (Martín-Alonso et al., 1992), was used to analyze
their effect in TRS-L binding (Fig. 2B). The objective of this
study was to select some antibodies for the subsequent analyses
of N protein RNA chaperone activity. EMSA studies showed
that mAbs recognizing the amino terminus domain of the
protein (1–241aa) significantly interfered with RNA binding,
inhibiting band shift (Fig. 2C), whereas mAbs specific for the
carboxy terminus did not hamper protein–RNA binding
leading to a supershift band in all cases. These bands probably
correspond to complex molecular aggregates of high molecular
Fig. 2. TRS-binding domain in TGEV N protein. (A) EMSA result after incubation of 300 ng of negative control, GST or GST-N proteins with 10 pmol of 5′-
biotinylated RNA oligonucleotides (Table 1). TRS, transcription-regulating sequence; cTRS, sequence complementary to the TRS; GST, glutathione S-transferase;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; ssRNA, single-stranded RNA. (B) Scheme of N protein domains and epitopes recognized by mAbs. Numbers
under the scheme indicate amino acid positions in the protein. SR, serine-rich domain; NS, nuclear localization signal; AD, acidic domain; RRM, RNA-recognition
motif. (C) EMSA result after incubation of 300 ng of protein and 1 pmol of TRS-L oligonucleotide. When indicated, on top of the lanes, recombinant N protein was
preincubated with the indicated mAb. The apparent difference between the band shift found in this case and in the gel in A is probably due to the fact that in this case
the electrophoresis was developed for a longer time in order to resolve the supershift complexes. Bottom, fragment of the EMSA result after longer electrophoresis
time, allowing the supershift complexes to enter the gel.
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a short distance. mAb 3B.H3, specific for the N-terminus of the
protein, did not interfere with RNA binding as it likely binds to
a different epitope than mAbs 3D.C10, 3C.E4, and 3C.D8. A
weak and diffuse band, migrating between the shifted and
supershifted bands, appeared only in the lanes including mAbs.
The presence of this band was probably due to minor RNA–
protein complexes formed between the viral RNA and proteins
present in the hybridoma supernatants used as the source of
mAbs as it is absent when hybridoma supernatants were not
added to the EMSA reactions (Fig. 2C, lanes 1 to 3). These
results suggested that the RNA-binding domain is likely locatedat the amino terminus half of the N protein, in agreement with
previously described RNA-binding domains of MHV, SARS-
CoV, and IBV (Fan et al., 2005; Huang et al., 2004; Nelson et al.,
2000). Additional experiments are needed to precisely determine
the exact RNA-binding motif of the protein.
Enhancement of avocado sunblotch viroid (ASBVd) ribozyme
self-cleavage by TGEV N protein
To analyze whether N protein acts in vitro as an RNA
chaperone, an advanced assay was used. ASBVd is a plant
viroid that requires a hammerhead-mediated self-cleavage of
219S. Zúñiga et al. / Virology 357 (2007) 215–227oligomeric ASBVd RNA during its replication following the
rolling circle mechanism (Daròs et al., 1994). One of the most
representative properties of nucleic acid chaperones is the
ability of these proteins to enhance hammerhead ribozyme
activity (Daros and Flores, 2002).
ASBVd positive-sense dimeric RNA was in vitro tran-
scribed and biotin labeled. The predicted secondary structure
for this RNA contains most of the nucleotides in dsRNA
regions, forming a rod-shaped structure with some stem-loops
at one end. For ribozyme cleavage, an RNA reorganization to
form two hammerhead ribozyme domains is required (Flores
et al., 2000). ASBVd RNA was incubated, in cleavage
conditions, in the absence or in the presence of recombinant
GST or GST-N proteins. In the absence of protein, the
transcript of 591 nt self-cleaved at 5 min yielding the
expected products, especially the 247 nt completely cleaved
RNA (Figs. 3A and B), although the self-cleavage reaction
made no progress with incubation time. The same effect wasFig. 3. Recombinant TGEV N protein enhances ribozyme self-cleavage. (A) Schem
arrowheads. Vector and viroid sequences are represented by black and gray bars,
Numbers on the right of the figure indicate the size, in nucleotides, of each RNA p
(25 ng) was incubated in the absence or presence of 300 ng of protein, and reaction m
lane, the reaction time (minutes) is indicated. Numbers on the left of the panel indicate
the cleavage products size. Uncleaved (591 nt) and completely cleaved (247 nt)
quantification of ribozyme self-cleavage reactions. Bands corresponding to unclea
background correction, the ratio of cleaved to uncleaved product was calculated base
deviation from three independent experiments.observed by incubating the RNA with GST protein. In
contrast, in the presence of GST-N protein, an enhancement
of ribozyme self-cleavage was observed, suggesting that N
protein had RNA chaperone activity. Other bands increased
their intensity with the incubation time and also appeared in
the absence of protein. These bands most likely resulted from
RNA cleavage at sites particularly prone to nuclease attack
(Daros and Flores, 2002). The increase in the appearance of
these bands, and also of RNA degradation, was probably due
to the RNA chaperone activity of N protein that facilitates
nuclease action (Levin et al., 2005). To exclude the possibility
of co-purification of an E. coli RNA chaperone with GST-N
protein and confirm that the increase in ribozyme cleavage
was due to TGEV N protein, the recombinant protein was
incubated with purified mAbs 3D.C10 (blocking RNA
binding) and 3B.D10 (that did not block this binding).
Monoclonal antibody 3D.C10 significantly inhibited the
ribozyme cleavage enhancement produced by the GST-Ne of the ASBVd in vitro transcript with ribozyme cleavage sites indicated by
respectively. All products resulting from ribozyme self-cleavage are indicated.
roduct. (B) Time-course of ribozyme self-cleavage reaction. Biotinylated RNA
ixture aliquots were collected and frozen at indicated time points. On top of each
the size markers (Mw) in nucleotides. Numbers on the right of the panel indicate
products are marked in gray. GST-hnA1, GST-hnRNPA1. (C) Densitometric
ved (591 nt) and completely cleaved (247 nt) products were measured. After
d on the division between these two intensities. Error bars indicate the standard
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replicates in human cells (Almazan et al., 2004), two human
cellular proteins were expressed and purified from E. coli and
tested as controls: (i) hnRNP A1, a nucleic acid chaperone
(Bertrand and Rossi, 1994; Herschlag et al., 1994; Portman
and Dreyfuss, 1994), and (ii) PTB, an RNA-binding protein
with no known RNA chaperone activity. To exclude that the
effect of the N protein was simply due to its RNA-binding
ability, the chaperone activity of recombinant His-PTB protein
was evaluated. No enhancement of ribozyme self-cleavage
was found with PTB protein (Fig. 3B), whereas recombinant
GST-hnRNPA1 protein produced an increase in the ribozyme
cleavage reaction similar to that observed with coronavirus N
protein, as expected for an RNA chaperone (Fig. 3B).
Densitometry of the RNA fragments produced by the
ribozyme self-cleavage from three independent experiments
showed that the enhancement of self-cleavage produced by
recombinant N protein was four-fold higher than in the
absence of protein (Fig. 3C). This cleavage increase was
comparable to that obtained in the presence of hnRNP A1
protein, a prototype RNA chaperone protein (Fig. 3C).
Preincubation of N protein with mAb 3D.C10, to prevent N
protein–RNA binding, reduced the ratio of cleaved to
uncleaved substrate to the levels obtained in the absence of
protein or in the presence of irrelevant proteins such as GST
or His-PTB (Fig. 3C), confirming that the increment of
ribozyme activity was specifically due to N protein. In
addition, preincubation of N protein with mAb 3B.D10, that
did not interfere with RNA–protein binding, enhanced the
ribozyme cleavage up to six-fold compared with the cleaved
to uncleaved ratio in the protein-free reactions (Fig. 3C). This
result showed that the N protein with the carboxy terminus
half blocked by the antibody was still active in the ribozyme
enhancement. The higher cleavage efficiency observed in the
presence of this mAb could be due to a change in the
conformation of this protein that favors its chaperone activity
or, alternatively, to the aggregation of the N protein caused by
the mAb.
TGEV N protein promotes viral TRS annealing
The RNA chaperone activity of recombinant N protein in
vitro was demonstrated with the ribozyme self-cleavage assay.
Nevertheless, ASBVd is a heterologous system evolutionary
distant from coronaviruses. Therefore, it was decided to
determine the influence of TGEV N protein in RNA annealing
reactions using coronavirus TRSs. Biotin-labeled TRS-L was
hybridized with different amounts of unlabeled cTRS-7 as the
annealing between TRS-L and cTRS-B is a crucial step in
template switch during coronavirus transcription (Sola et al.,
2005; Zuñiga et al., 2004). TRS-L oligonucleotide could
generate species with different mobility (ssRNA′), apart from
the single-stranded RNA (ssRNA) band indicated (Fig. 4A).
TRS-L and cTRS-7 oligonucleotides annealed in vitro in the
absence of protein. Nevertheless, TGEV N protein promoted
their annealing (Fig. 4B). The increase in annealing promoted by
N protein was noted even in the presence of magnesium (data notshown) that stabilized double-stranded RNAs (dsRNAs). In the
reaction conditions, there was no change in the amount of
ssRNA′ species. As the incubations were performed for 30 min,
it is possible that this band could disappear with longer
incubation times. At this moment, there are no available data
indicating whether the ssRNA′ species are unproductive TRS-L
conformations or whether they are intermediate products that
accumulate in the generation of the dsRNA. The increased
annealing was reproduced in three experiments, and the ratio of
dsRNA to ssRNAwas quantified after resolving these RNAs in a
gel. Recombinant N protein significantly increased the ratio of
dsRNA to ssRNA (Fig. 4C). This effect was due to N protein and
not to molecular crowding as GST protein alone, used in the
same molar amount, did not exert any influence on TRSs
annealing (Figs. 4B and C). Specific binding of PTB to viral
TRSs (Zuñiga S., Sola I., Moreno J.L. and Enjuanes L.,
unpublished results) did not promote TRSs annealing reaction
(Figs. 4B and C), confirming the TGEV N protein RNA
chaperone activity in the context of coronavirus TRSs.
TGEV N protein promotes DNA oligonucleotide annealing
RNA chaperones promote nucleic acids annealing and also
unwinding. Therefore, the final ratio of double to single-
stranded nucleic acid detected is the result of both activities. The
nature of the oligonucleotides used in the assay and the ionic
strength of the solution also influence annealing reactions (Levin
et al., 2005). Therefore, to reinforce the conclusions obtained
from the annealing of viral RNAs, similar reactions were
performed using previously described DNA oligonucleotides
(Huang et al., 2003) (Fig. 5A), expecting that, as an RNA
chaperone, TGEV N protein could also promote DNA
annealing. In the presence of recombinant N protein, the level
of dsDNAwas significantly higher than in its absence or in the
presence of control proteins, such as GST and PTB. The
annealing promoted by N protein was similar to that obtained in
the presence of a reference RNA chaperone such as hnRNPA1
(Fig. 5B). Furthermore, after annealing reactions, proteinase K
was added to eliminate the protein from the reaction mixture, and
the amount of dsDNA did not significantly decrease after
annealing promotion by N or hnRNPA1 (Fig. 5B), as expected
for RNA chaperones. These data confirmed that TGEV N
protein behaves as a nucleic acid chaperone.
RNA chaperone activity of SARS-CoV N protein
Despite the poor conservation of coronavirus N protein
sequences, regions with functional relevance are highly
conserved. Predicted secondary structure and disordered regions
of coronavirus N proteins are also conserved (Calvo et al., 2005)
(Fig. 1). To investigate whether RNA chaperone activity was
present in other coronavirus N proteins, SARS-CoV N protein
was selected as it is relatively distant from TGEVN protein with
only 34% amino acid identity between them. The self-cleavage
of biotin-labeled ASBVd dimeric RNA was monitored in the
absence or in the presence of SARS-CoV N-His protein
expressed by a recombinant baculovirus and purified from
Fig. 4. Recombinant TGEVN protein promotes viral TRSs annealing. (A) Scheme of the duplex formed by viral TRS-L and cTRS-7 and the possible structures formed
by TRS-L. (B) Annealing reactions in the absence or presence of 300 ng of recombinant protein. Biotin-labeled TRS-L 0.025 μM was incubated with 0.025 μM of
unlabeled cTRS-7. PTB, His-PTB. (C) Annealing of TRS-L and cTRS-7 was repeated three times, and the bands indicated as dsRNA and ssRNAwere quantified.
Ratio of dsRNA to ssRNA is presented for each case. Error bars indicate the standard deviation.
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self-cleavage (Fig. 6A), indicating that this protein has RNA
chaperone activity. RNA degradation was stronger in these
reactions compared with that obtained in the presence of TGEV
N protein. This increase could be due to a higher chaperone
activity of the N-His protein, leading to an increased nuclease
activity. Densitometry of the RNAs from three independent
experiments showed that N-His protein enhanced ribozyme
cleavage up to ten-fold compared with the protein free reactions
(Fig. 6B). The higher enhancement efficiency of SARS-CoV N
protein, in relation to that of TGEV N protein, was possibly due
to a more native conformation of SARS-CoV N protein as a
consequence of the presence of a smaller tag, distant from RNA-binding domain, located in the carboxy terminus, or to the
expression of this protein in insect cells, leading to a protein with
post-translational modifications such as phosphorylation.
Discussion
The RNA chaperone activity of two coronavirus N proteins
is described, representing the first report of a coronavirus
protein with RNA chaperone activity. N protein has a structural
role in coronavirus assembly (Risco et al., 1996), and there is a
growing evidence for a role of this protein in RNA synthesis
(Almazan et al., 2004; Baric et al., 1988; Nelson et al., 2000;
Schelle et al., 2005; Stohlman et al., 1988). In addition, N
Fig. 5. Recombinant TGEV N protein promotes DNA oligonucleotides annealing. (A) Scheme of the duplex formed by DNA oligonucleotides C and B (Huang et al.,
2003). (B) Annealing reactions in the absence or presence of 300 ng of recombinant protein. Biotin-labeled oligo C 0.5 nM was incubated with 0.4 nM of unlabeled
oligo B. The bands corresponding to dsDNA (B+C) and ssDNA (C) are indicated. After the annealing reaction was completed, proteinase K (150 μg/ml) was added to
eliminate the protein when indicated. N, GST-N; hnA1, GST-hnRNP A1; PTB, His-PTB.
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such as induction of apoptosis or cell-cycle arrest (He et al.,
2003; Surjit et al., 2004). The relevance of N protein in
coronavirus RNA synthesis, its nonspecific binding to RNA and
its intrinsic disorder led us to investigate N protein potential
nucleic acid chaperone activity. It was found that, at least inFig. 6. Enhancement of ribozyme self-cleavage by recombinant SARS-CoV N
protein. (A) Time-course of ASBVd ribozyme self-cleavage reaction, performed
as previously described (see above). On top of each lane, reaction time (minutes)
is indicated. Numbers on the left of the panel indicate the molecular mass (Mw)
in nucleotides. Numbers on the right of the panel indicate the cleavage products
in nucleotides. Uncleaved (591 nt) and completely cleaved (247 nt) products are
marked in gray. Note that the gel corresponding to the reaction in the absence of
protein is over-exposed to detect cleavage products and smaller bands. (B)
Densitometric quantification of ribozyme self-cleavage reactions. Error bars
indicate the standard deviation from three independent experiments.vitro, TGEV N protein had RNA chaperone activity, enhancing
ASBVd hammerhead ribozyme self-cleavage as typical RNA
chaperones do (Daros and Flores, 2002). These results imply
that N protein promotes the correct folding of the hammerhead
ribozyme avoiding unproductive RNA conformations, therefore
acting as an RNA chaperone. Interestingly, it was found that N
protein also promotes annealing in vitro of DNA and viral TRS
RNAs, confirming its role as an RNA chaperone in a
coronavirus-related system.
TGEV N protein binding domain for TRS RNA is likely
located within the first 241 aa of this protein as mAbs specific
for this region significantly inhibited RNA-N binding. This
result agrees with previous data locating MHVN leader-binding
domain between aa 177 and 231, a region including the Ser-rich
motif conserved in all coronavirus N proteins (Nelson et al.,
2000).
N protein primary sequence is not highly conserved among
coronaviruses from different groups, although some sequence
motifs with functional relevance are highly conserved. The
predicted secondary structure of N proteins is also conserved
(Calvo et al., 2005). It was recently described that RNA
chaperones are the protein class with the highest frequency of
long intrinsically disordered regions. These domains frequently
have high functional relevance, and an entropy transfer model
for chaperone function has been proposed (Tompa and
Csermely, 2004). According to this model, binding of an
RNA chaperone to the substrate (RNA) is accompanied by local
folding of the previously disordered regions of the protein, with
a concomitant unfolding of an RNA region. After several cycles
of disorder-to-order and order-to-disorder transitions, the final
result is that the RNA is folded in the proper conformation and
released to form the RNA chaperone (Tompa and Csermely,
2004). Prediction of disordered regions in N proteins from
several coronaviruses showed that there is a great conservation
in the length, position, and frequency of these regions. In
addition, our experimental data indicated that SARS-CoV N
protein has also RNA chaperone activity. All these observations
223S. Zúñiga et al. / Virology 357 (2007) 215–227led us to postulate that RNA chaperone activity is not an
exclusive characteristic of TGEV N protein, but might be a
general activity of all coronavirus nucleoproteins.
The phosphorylation of TGEV N protein has been recently
reported (Calvo et al., 2005). A comparable post-translational
modification has also been described for IBV N protein (Chen et
al., 2005). The role of phosphorylation is still unclear, although
it was proposed that phosphorylated IBV N protein preferen-
tially binds viral than cellular RNAs (Chen et al., 2005). It is
worth noting that the recombinant TGEV N protein used in this
study was not post-translationally modified as it was expressed
in E. coli. Nevertheless, this N protein bound viral TRSs and
had RNA chaperone activity, indicating that phosphorylation is
not essential for N protein chaperone activity. On the other
hand, SARS-CoV N-His protein showed higher activity than
TGEV N protein. SARS-CoV N-His protein was expressed
using a baculovirus system, allowing post-translational mod-
ifications. Therefore, it is tempted to speculate that perhaps a
post-translational modification, such as N protein phosphoryla-
tion, could increase its RNA chaperone activity or have a role in
RNA-binding affinity.
Due to the large size of coronavirus RNA genome and the
template switch required during transcription, coronavirus RNA
synthesis may require the assistance of RNA chaperones.
Recent data showed that the free energy of the duplex formation
between cTRS-B and TRS-L is probably the main factor,
although not the only one, in coronavirus discontinuous
transcription (Sola et al., 2005; Zuñiga et al., 2004). An energy
barrier must be overcome to dissociate the nascent minus RNA
chain from the genomic template and to perform a template
switch with the TRS of the leader. RNA chaperones are proteins
that could decrease this energy threshold.
Other cellular RNA chaperones may also exert in vivo an
effect on coronavirus RNA synthesis. In fact, the hnRNP A1
protein, binding coronavirus RNA (Huang and Lai, 2001; Shi et
al., 2000), is an RNA chaperone (Bertrand and Rossi, 1994;
Pontius and Berg, 1992; Portman and Dreyfuss, 1994).
Nevertheless, previous data on coronavirus RNA synthesis
(Almazan et al., 2004; Schelle et al., 2005) generated in the
presence of cellular chaperones and in the absence of N protein
indicate that N protein has an important role in coronavirus
RNA synthesis. To our knowledge, the activity of a virus-
encoded RNA chaperone in vivo using a mammalian system
has not been described as the in vivo data reported up to date
have been generated using a bacterial RNA folding trap (Clodi
et al., 1999). Work in progress in our laboratory is focused to
determine the role of the N protein in vivo as an RNA chaperone
in coronavirus transcription, especially in template switch,
taking advantage of the reverse genetics tools available.
Materials and methods
Plasmid constructs
TGEVNgene, nucleotides 26,917 to 28,065 from the genome
(GeneBank accession number AJ271965), was amplified by
PCR using the TGEV infectious cDNA as template (Almazán etal., 2000), oligonucleotides N1 (5′-ATGGCCAACCAGGGA-
CAACGTG-3′) and N1148 (5′-TTAGTTCGTTACCTCAT-
CAATTATC-3′) and Platinum Pfx polymerase (Invitrogen)
according to manufacturer's instructions. The 1149 bp PCR
product was cloned on pGEX-4T-2 vector (Amersham Bios-
ciences) digested with SmaI. The resulting pGEX4T2-N plasmid
directed the expression of a recombinant GST-N fusion protein.
SARS-CoV Urbani strain N gene, nucleotides 28,120 to
29,388 from the genome (GeneBank accession number
AY278741), was amplified by PCR using as template the
SARS-CoVcDNAclone(Almazanetal.,2006),oligonucleotides
SARS-N-VS (5′-CACGGAATTCATGTCTGATAATG-
GACCCCAATC-3′) and SARS-N-RS (5′-GTACGCTC-
GAGTGCCTGAGTTGAATCAGCAGAAG-3′) and Platinum
Pfxpolymerase (Invitrogen) according tomanufacturer's instruc-
tions. The 1286 bp PCR product was digested with EcoRI and
XhoI restriction enzymes and cloned in the donor plasmid pFast-
BAC-Cter-HisTag, a generousgift fromA.Alcamí (CNB,CSIC).
The resulting pFastBac-N-SARS-Cter-HisTag was the donor
plasmid for the expression of a recombinantN-His fusionprotein.
Human hnRNP A1 isoform A was cloned from plasmid
pET9d-hnRNPA1, kindly provided by A. Krainer (Cold Spring
Harbor Laboratory). The gene was amplified by PCR using
oligonucleotides hnRNPA1-VS (5′-CGGGATCCATGTC-
TAAGTCAGAGTCTCC-3′) and hnRNPA1-RS (5′-
CCGAATTCTTAAAATCTTCTGCCACTGC-3′) and Plati-
num Pfx polymerase (Invitrogen) according to manufacturer's
instructions. The 1119 bp PCR product was digested with
BamHI and EcoRI restriction enzymes and cloned in the same
sites of pGEXT-4T-2. The resulting pGEX4T2-hnRNPA1
plasmid directed the expression of a recombinant GST-
hnRNPA1 fusion protein.
All cloning steps were checked by sequencing the PCR
amplified fragments, fusion genes, and cloning junctions.
Plasmids pET28a-PTB (Xie et al., 2003) and pBdASBVd
[A28] (Daros and Flores, 2002) were generous gifts from D.
Black (Howard Hughes Medical Institute, UCLA) and J.A.
Daròs (Plant Molecular and Cell Biology Institute, UPV),
respectively.
Recombinant baculovirus expressing SARS-CoV N protein
Bac-to-Bac Baculovirus Expression System (Invitrogen) was
used following manufacturer's instructions. Briefly, the recom-
binant baculovirus genome was obtained by electroporation of
E. coli DH10Bac cells (Invitrogen) as described (Airenne et
al., 2003). To obtain the recombinant baculovirus, High Five
insect cells were transfected using Cellfectin reagent (Invitro-
gen) following manufacturer's specifications. Cytopathic effect
was observed at 72 h post-transfection, and the supernatant
containing the recombinant baculovirus was harvested at 5 days
post-transfection.
Protein expression and purification
E. coli cells of the strain BL21(DE3)pLys (Novagen) were
transformed with plasmids pGEX-4T-2, pGEX4T2-N,
Table 1
RNA oligonucleotides







a When indicated: Bio=Biotin. CS (conserved core sequence) is underlined.
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GST-hnRNPA1 expression and purification, a 250 ml culture
was grown at 37 °C to approximately 0.5 OD600. Protein
expression was induced with 1 mM ITPG for 4 h at 30 °C. The
cell pellet was resuspended in CelLytic B II (Sigma) with
Protease Inhibitor Cocktail (Sigma), and protein extract was
obtained following manufacturer's instructions. From this
extract, recombinant proteins were purified using glutathione
Sepharose 4B (Amersham Biosciences) according to manufac-
turer's specifications. His-PTB protein was purified as pre-
viously described (Xie et al., 2003), using the same bacterial
lysis protocol and HIS-Select Nickel affinity gel (Sigma)
following manufacturer's instructions. To purify SARS-CoV N-
His protein, High Five insect cells were grown on 150 mm
plates and infected with the recombinant baculovirus. At 48 hpi,
the cells were harvested and resuspended in lysis buffer (50 mM
sodium phosphate buffer pH 8.0, 300 mM NaCl, 0.05% Tween-
20, and 1% NP-40) with Protease Inhibitor Cocktail (Sigma).
The protein extract was recovered after 10 min incubation on ice
and 10min centrifugation 10,000×g at 4 °C. Recombinant N-His
protein was purified from this extract using HIS-Select Nickel
affinity gel (Sigma) following manufacturer's instructions.
All the purification steps were followed by Coomassie
staining, using EZBlue (Sigma), and by Western blot analysis
with specific antibodies. To detect GST-N and N-His proteins,
mAbs 3D.H10 (Martín-Alonso et al., 1992) and anti-
polyhistidine peroxidase conjugated antibody (Sigma) were
used, respectively. Recombinant GST-hnRNPA1 protein was
detected using polyclonal antibody E-17 (Santa Cruz Bio-
technology). Hybridoma cells BB7, producing mAb against
human PTB, used for His-PTB detection, were purchased
from ATCC.
RNAs
5′ biotinylated or unmodified RNA oligonucleotides,
described in Table 1, were purchased form CureVac (Tübingen,
Germany). Biotin-labeled dimeric ASBVd (+) RNA was
synthesized by in vitro transcription of XbaI linearized
pBdASBVd[A28] template, using MEGAscript T7 kit
(Ambion) and biotin-14-CTP (Invitrogen), following manufac-
turer's instructions. The transcript was purified by 2% low-
melting agarose gel electrophoresis. After electrophoresis, the
band corresponding to the non-cleaved biotinylated RNA was
cut andmelted at 60 °C. The RNAwas cleaned using the RNeasy
Mini kit (Qiagen), according to manufacturer's specifications
and eluted in 1 mM EDTA pH 8.0.
IgGs purification
mAbs 3D.C10 and 3B.D10 (Martín-Alonso et al., 1992)
were isolated from hybridoma culture supernatants using the
Protein A Antibody Purification Kit (Sigma) according to
manufacturer's instructions. To minimize nuclease contamina-
tion during the assays, these purified antibodies were used in the
presence of a broad range nuclease inhibitor (SUPERase•In,
Ambion).Electrophoretic mobility shift assay (EMSA)
RNA–protein binding reactions were performed by incubat-
ing 10 or 1 pmol of biotinylated probe (Table 1) with 300 ng of
recombinant purified protein in binding buffer (12% glycerol,
20 mM TrisHCl pH 7.4, 50 mM KCl, 1 mM EDTA, 1 mM
MgCl2, 1 mM DTT) 30 min at 25 °C. Reactions were loaded on
a 4% non-denaturing PAGE that was run on TBE 0.5× at 150 V
and 4 °C. After electrophoresis, the gel was blotted onto
positively charged nylon membranes (BrightStar-Plus,
Ambion) following manufacturer's instructions. Detection of
the biotinylated RNA was performed using the BrightStar
BioDetect kit (Ambion). When indicated, recombinant protein
was previously incubated with mAb 30 min at 4 °C.
In vitro self-cleavage of RNA
Cleavage of biotin-labeled dimeric ASBVd (+) RNA was
performed as previously described (Daros and Flores, 2002).
Briefly, 25 ng of biotinylated RNA was incubated, under
cleavage conditions, in the absence or the presence of 300 ng of
recombinant protein. To minimize RNA degradation, 20 units of
RNase inhibitor (SUPERase•In, Ambion) was added to the
reactions. RNAs were separated by 5% denaturing PAGE. After
electrophoresis, the gel was blotted and biotinylated RNAs were
detected as described for the EMSA. When indicated,
recombinant protein was previously incubated with 1 μl of
purified mAb 30 min at 4 °C. As total RNA amount decreases
with the incubation time, due to nuclease action, to estimate
cleavage ratio, densitometric analysis of the 591 (uncleaved)
and 247 nt (cleaved) bands was performed using Quantity One
4.5.1 Software (BioRad). In addition to be the possibly most
logical reference for the cleavage reaction, it provided the same
results that if other intermediate cleavage products would have
been chosen for the quantification. At least three different
experiments and appropriate gel exposures were used in all
cases with similar results. In addition, different exposures of the
same reactions were densitometered to assure that data were
obtained from films within the linear range.
Annealing of RNA oligonucleotides
Biotinylated TRS-L oligonucleotide (Table 1) 0.025 μMwas
incubated with the same amount of unlabeled cTRS-7
oligonucleotide, in annealing buffer (40 mM TrisHCl pH 7.9,
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incubated 2 min at 95 °C and snap-cooled on ice. RNase inhi-
bitor (20 U) and protein (300 ng) were added and reactions were
incubated 30 min at 37 °C. Reactions were stopped by adding
1 μl of ice-cold stop solution (50 mM EDTA, 2.5% SDS, 25%
glycerol, 0.01% xylene cyanol, 0.01% bromophenol blue).
Samples were loaded on a 15%RNAnon-denaturing PAGEwith
0.1% SDS. After electrophoresis, the gel was blotted and
biotinylated RNAs were detected as described for the EMSA.
Densitometric analysis of the dsRNA and ssRNA bands from
three different experiments was performed using Quantity One
4.5.1 Software (BioRad).
Annealing of DNA oligonucleotides
Previously described (Huang et al., 2003) oligonucleotides C
and B were used. Biotinylated oligonucleotide C (0.5 nM) was
incubated with unlabeled B oligonucleotide (0.4 nM), in
annealing buffer (40 mM TrisHCl pH 7.9, 100 mM NaCl,
20 μM EDTA, 2% glycerol). This mix was incubated 2 min at
95 °C and snap-cooled on ice. Indicated proteins (300 ng) were
added, and reactions were incubated 20 min at 37 °C. When
indicated, proteinase K (150 μg/ml) was added and the reactions
were incubated 10 min at 37 °C. In all cases, reactions were
stopped by adding 1 μl of ice-cold stop solution (50 mM EDTA,
2.5% SDS, 25% glycerol, 0.01% xylene cyanol, 0.01%
bromophenol blue). Samples were loaded on a 15% non-
denaturing PAGE with 0.1% SDS. Biotinylated DNA was
detected as described for the RNA annealing experiments.
In silico analysis of protein disorder
Coronavirus N proteins from several groups were analyzed
using the DisProt VL3H predictor based on neural networks
(Obradovic et al., 2003; Peng et al., 2005). N protein
sequences used were from TGEV (GeneBank accession
number AJ271965), HCoV-229E (GeneBank accession num-
ber AF304460), MHV strain A59 (GeneBank accession
number AF029248), SARS-CoV Urbani strain (GeneBank
accession number AJ278741), and IBV Beaudette strain
(GeneBank accession number M95169).
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